Olon USA is enjoying an exciting week in San Francisco, where we are attending two key events for the biotech and healthcare industries: the 43rd annual J.P. Morgan Healthcare Conference and the Biotech Showcase. Both of these events are invaluable opportunities for networking, learning about the latest trends, and showcasing the capabilities of Olon USA.
Why Olon USA is Excited to Attend
For our team, these events provide the perfect platform to introduce Olon USA to new potential clients, build relationships, and discuss how we can help de-risk their drug development programs. Both Nerissa Chu-A-Kong and Johnny Chapman, Business Development Directors at Olon USA, are on the ground meeting with investors, startups, and established pharma companies.
Olon USA is in a unique position: we combine the agility and personalized service of a smaller company with the stability of our parent company, Olon Group. This allows us to offer the best of both worlds—tailored solutions for early-stage projects with the security of a larger, worldwide infrastructure.
Nerissa’s Longstanding Experience at JP Morgan
Nerissa Chu-A-Kong is no stranger to the J.P. Morgan Healthcare Conference, she first attended 15 years ago. She explains that the conference has evolved, with more startups attending each year. Many of these startups are in their early stages and need support for funding and drug development.
“For us at Olon USA, we’re here to support those early-phase biotech companies with the services they need, whether it’s contract development, manufacturing, or risk mitigation,” Nerissa says. “We may not be the ones investors come to initially, but we are here to make those crucial connections and offer solutions when the time comes.”
Johnny’s Excitement for Biotech Showcase
This is Johnny Chapman’s first time attending the Biotech Showcase, and he is enjoying meeting with potential clients and investors. Having traditionally attended East Coast shows, Johnny is exploring opportunities in the West Coast market and engaging with entrepreneurs who need the high-quality services that Olon USA offers.
“I’m excited to introduce Olon USA to a new audience and let them know that we’re here to help bring their ideas to life,” Johnny says. “We are experts in managing complex projects and providing the support necessary for biotech companies to succeed.”
Olon USA: The Perfect Mix of Flexibility and Expertise
As a small-to-mid-sized CDMO, Olon USA is perfectly positioned to work with biotech companies at all stages of their development. From early-phase, preclinical programs to commercial-scale manufacturing, we provide customized solutions that cater to the specific needs of each client.
But what sets us apart is our ability to also offer the stability and resources of our parent company, Olon Group, a globally recognized leader in the pharmaceutical manufacturing space. This gives our clients the best of both worlds: the personalized, flexible service of a smaller company and the assurance of long-term reliability backed by a global network.
Expanding Capabilities at Olon USA
Olon USA continues to grow, both in talent and capabilities. As Nerissa points out, one of the most exciting developments is the addition of highly potent capabilities at our Ohio-based facility. These capabilities allow us to handle more complex projects, including those involving highly potent active pharmaceutical ingredients (HPAPIs).
On the global stage, Olon Group is expanding through acquisitions, further increasing our resources and expertise in drug product development and chemistry. This enables us to continue offering cutting-edge solutions to our clients, whether they are working on early-phase research or preparing for large-scale manufacturing.
Networking Opportunities at the Biotech Showcase
At the Biotech Showcase, Olon USA is excited to participate in numerous side events, receptions, and networking opportunities. From informal meet-and-greets to more structured partnering sessions, these events allow us to engage with entrepreneurs, investors, and other industry leaders in meaningful ways.
Johnny is particularly excited about the many spinoff events from the Biotech Showcase, including those focused on non-dilutive funding, and looks forward to learning more about funding opportunities available to entrepreneurs in the U.S. Nerissa, meanwhile, is attending a “Non-Dilutive Funding Summit” hosted by Free Mind Group today, where she is engaging with entrepreneurs looking for ways to fund their programs while minimizing dilution.
Both Nerissa and Johnny are actively involved in the various events happening at the Biotech Showcase, meeting potential clients and partners, and gathering insights on the future direction of the biotech industry.
Olon USA’s Expanding Presence and Growth
Olon USA’s growth is reflected in the addition of new faces like Nerissa and Johnny, who are representing new territories across the U.S. As business development directors, they are helping Olon USA expand its presence and connect with more clients in key regions. Johnny covers the Western United States, including Texas, California, and the West Coast, while Nerissa oversees the Northeastern U.S., covering areas from New York to Maryland and beyond.
Their combined experience and regional knowledge position Olon USA to support both new and established biotech companies across the U.S. as they navigate the challenges of drug development.
Looking Ahead and What It Means for 2025
For Olon USA, JP Morgan Healthcare Conference and Biotech Showcase are not only about showcasing our capabilities but also about learning from industry leaders and gaining valuable insights into the future of biotech and pharma. These events are an opportunity to meet face-to-face with entrepreneurs and investors and begin building lasting relationships that will help move the industry forward.
If you’re planning to attend either of these events, be sure to stop by and meet Nerissa and Johnny. They’ll be ready to discuss how Olon USA’s expertise, combined with the stability of Olon Group, can help bring your drug development projects to life.
Meet with Us in San Francisco!
Olon USA is having a wonderful and productive week at both the J.P. Morgan Healthcare Conference and Biotech Showcase. We’re ready to make connections, offer solutions, and help drive success for biotech startups and investors alike. If you’re attending these events, don’t hesitate to reach out to Nerissa and Johnny—they are happy to meet and discuss how we can support your drug development needs.
Schedule a time to meet with Nerissa and Johnny while they are in San Fransisco this week and let’s make 2025 a year of innovation and collaboration! For more information about Olon USA and how we can support your drug development programs, feel free to reach out directly to Nerissa Chu-A-Kong (Northeastern U.S.) or Johnny Chapman (Western U.S.) at the events.